These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15742642)

  • 1. The use of antigen and vaccine banks in case of emergency vaccination in the European community.
    Füssel AE
    Dev Biol (Basel); 2004; 119():307-15. PubMed ID: 15742642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global virtual network for foot-and-mouth disease in case of emergency.
    Palma EL
    Dev Biol (Basel); 2004; 119():317-31. PubMed ID: 15742643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the foot-and-mouth disease module to the control of other diseases.
    De Clercq K; Goris N
    Dev Biol (Basel); 2004; 119():333-40. PubMed ID: 15742644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian contingency plans for emergency animal disease control: the role of antigen/vaccine banks.
    Tweddle NE
    Dev Biol (Basel); 2004; 119():295-306. PubMed ID: 15742641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory considerations for emergency use of vaccines in the European Union.
    Pastoret PP; Mackay D
    Dev Biol (Basel); 2003; 114():53-8. PubMed ID: 14677676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of foot and mouth disease virus antigens in transgenic plants].
    Dus Santos MJ; Wigdorovitz A
    Rev Sci Tech; 2005 Apr; 24(1):175-87. PubMed ID: 16110887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot and mouth disease: the future of vaccine banks.
    Forman AJ; Garland AJ
    Rev Sci Tech; 2002 Dec; 21(3):601-12. PubMed ID: 12523700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Occurrence of foot and mouth disease--a historical survey].
    Thalmann G; Nöckler A
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):484-94. PubMed ID: 11822161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines and foot-and-mouth disease eradication in South America.
    Saraiva V
    Dev Biol (Basel); 2003; 114():67-77. PubMed ID: 14677678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
    Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
    Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of foot and mouth disease].
    Haas B
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):508-13. PubMed ID: 11822165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
    Niedbalski W
    Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Point of view of KNMvD concerning foot and mouth disease marker vaccine].
    van Leeuwen JM
    Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.